Arachis

• 

  Subject Areas on Research

  • A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. 
  • Clinical efficacy and immune regulation with peanut oral immunotherapy. 
  • Effects of cooking methods on peanut allergenicity. 
  • Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. 
  • Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. 
  • Evaluating pH-induced gastrointestinal aggregation of Arachis hypogaea 1 fragments as potential components of peanut allergy. 
  • Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge. 
  • Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. 
  • Immunology in the Clinic Review Series; focus on allergies: immunotherapy for food allergy. 
  • Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. 
  • Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. 
  • Modification of a major peanut allergen leads to loss of IgE binding. 
  • Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. 
  • Peanut allergy: recurrence and its management. 
  • Peanut and soy allergy: a clinical and therapeutic dilemma. 
  • Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials. 
  • Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. 
  • Protein structure plays a critical role in peanut allergen stability and may determine immunodominant IgE-binding epitopes. 
  • Safety of a peanut oral immunotherapy protocol in children with peanut allergy. 
  • Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradation. 
  • Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. 
  • Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. 
  • The natural progression of peanut allergy: Resolution and the possibility of recurrence. 
  • Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice. 
• 

  Keywords of People

  • Zhong, Xiaoping, Professor of Pediatrics, Immunology